{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T08:31:19Z","timestamp":1774945879602,"version":"3.50.1"},"reference-count":25,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004417","name":"The Global Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004417","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004417","name":"The Global Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004417","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Indian Journal of Tuberculosis"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.ijtb.2020.02.008","type":"journal-article","created":{"date-parts":[[2020,2,28]],"date-time":"2020-02-28T16:28:30Z","timestamp":1582907310000},"page":"216-221","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Ocular adverse events in drug sensitive TB patients on daily fixed dose combination anti-TB drugs: A record review study from Kerala, India"],"prefix":"10.1016","volume":"67","author":[{"given":"Muraleedharan Sarojini","family":"Manu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kedar","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mrinalini","family":"Das","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shibu","family":"Balakrishnan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mrithyunjayan","family":"Sunil kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.S.","family":"Rakesh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.P.","family":"Sindhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mathew J.","family":"Valamparampil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.S.","family":"Neena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Srinath","family":"Satyanarayana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijtb.2020.02.008_bib1","series-title":"Global tuberculosis report 2017","first-page":"1","year":"2017"},{"key":"10.1016\/j.ijtb.2020.02.008_bib2","series-title":"National strategic plan for tuberculosis elimination 2017-2025; Directorate general of health services","year":"2017"},{"key":"10.1016\/j.ijtb.2020.02.008_bib3","series-title":"Technical and operational guidelines for TB control in India","year":"2016"},{"key":"10.1016\/j.ijtb.2020.02.008_bib4","doi-asserted-by":"crossref","first-page":"S80","DOI":"10.1016\/j.cegh.2015.10.005","article-title":"Prevalence of adverse drug reaction with first-line drugs among patients treated for pulmonary tuberculosis","volume":"3","author":"Singh","year":"2015","journal-title":"Clin Epidemiol Glob Heal"},{"key":"10.1016\/j.ijtb.2020.02.008_bib5","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1164\/rccm.200206-626OC","article-title":"Incidence of serious side effects from first-line antituberculosis drugs among patients treated for active tuberculosis","volume":"167","author":"Yee","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ijtb.2020.02.008_bib6","first-page":"868","article-title":"Adverse drug reactions associated with first-line anti-tuberculosis drug regimens","volume":"11","author":"Marra","year":"2007","journal-title":"Int J Tuberc Lung Dis"},{"issue":"10","key":"10.1016\/j.ijtb.2020.02.008_bib7","first-page":"531","article-title":"A study of adverse drug reactions caused by first line anti-tubercular drugs used in Directly Observed Treatment, Short course (DOTS) therapy in western Nepal, Pokhara","volume":"58","author":"Chhetri","year":"2008","journal-title":"J Pak Med Assoc"},{"issue":"10","key":"10.1016\/j.ijtb.2020.02.008_bib8","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1016\/j.rmed.2006.01.014","article-title":"Side effects due to primary antituberculosis drugs during the initial phase of therapy in 1149 hospitalized patients for tuberculosis","volume":"100","author":"G\u00fclbay","year":"2006","journal-title":"Respir Med"},{"issue":"4","key":"10.1016\/j.ijtb.2020.02.008_bib9","doi-asserted-by":"crossref","first-page":"325","DOI":"10.4046\/trd.2009.67.4.325","article-title":"The influence of adverse drug reactions on first-line anti-tuberculosis chemotherapy in the elderly patients","volume":"67","author":"Jeong","year":"2009","journal-title":"Tuberc Respir Dis"},{"issue":"1","key":"10.1016\/j.ijtb.2020.02.008_bib10","doi-asserted-by":"crossref","first-page":"16","DOI":"10.4103\/2229-3485.124557","article-title":"Revised National Tuberculosis Control Program regimens with and without directly observed treatment, short-course: a comparative study of therapeutic cure rate and adverse reactions","volume":"5","author":"Sivaraj","year":"2014","journal-title":"Perspect Clin Res"},{"issue":"3","key":"10.1016\/j.ijtb.2020.02.008_bib11","first-page":"213","article-title":"Toxic ocular effects of ethambutol","volume":"137","author":"Kahana","year":"1987","journal-title":"Can Med Assoc J"},{"key":"10.1016\/j.ijtb.2020.02.008_bib12","doi-asserted-by":"crossref","first-page":"7052","DOI":"10.1167\/iovs.12-10308","article-title":"Retinal function and morphology in monkeys with ethambutol-induced optic neuropathy","volume":"53","author":"Kinoshita","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ijtb.2020.02.008_bib13","first-page":"190","article-title":"Ethambutol is toxic to retinal ganglion cells via an excitotoxic pathway","volume":"40","author":"Zurakowski","year":"1999","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ijtb.2020.02.008_bib14","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1097\/WNO.0b013e3182901969","article-title":"Drug-related mitochondrial optic neuropathies","volume":"33","author":"Wang","year":"2013","journal-title":"J Neuro Ophthalmol"},{"key":"10.1016\/j.ijtb.2020.02.008_bib15","first-page":"401","article-title":"Isoniazid and Ethambutol as a cause of optic neuropathy","volume":"71","author":"Jimenez \u2013 Lucho","year":"1987","journal-title":"Eur J Respir Dis"},{"issue":"June","key":"10.1016\/j.ijtb.2020.02.008_bib16","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1590\/S1806-37132010000500016","article-title":"Antituberculosis drugs: drug interactions, adverse effects, and use in special situations. Part 1: first-line drugs","volume":"36","author":"Arbex","year":"2010","journal-title":"J Bras Pneumol"},{"issue":"1","key":"10.1016\/j.ijtb.2020.02.008_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4103\/0970-2113.148395","article-title":"Ocular toxicity with ethambutol therapy: timely recaution","volume":"32","author":"Koul","year":"2015","journal-title":"Lung India"},{"issue":"11","key":"10.1016\/j.ijtb.2020.02.008_bib18","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1136\/bjophthalmol-2012-301870","article-title":"Ethambutol-induced optic neuropathy: a nationwide population-based study from Taiwan","volume":"96","author":"Chen","year":"2012","journal-title":"Br J Ophthalmol"},{"issue":"7","key":"10.1016\/j.ijtb.2020.02.008_bib19","first-page":"622","article-title":"Ethambutol and optic neuropathy","volume":"86","author":"Chuenkongkaew","year":"2003","journal-title":"J Med Assoc Thai"},{"issue":"1077","key":"10.1016\/j.ijtb.2020.02.008_bib21","first-page":"428","article-title":"Ocular toxicity from ethambutol: a review of four cases and recommended precautions","volume":"111","author":"Sivakumaran","year":"1998","journal-title":"N Z Med J"},{"key":"10.1016\/j.ijtb.2020.02.008_bib22","first-page":"56","article-title":"Ocular toxicity of ethambutol","volume":"12","author":"Chan","year":"2006","journal-title":"Hong Kong Med J"},{"issue":"12","key":"10.1016\/j.ijtb.2020.02.008_bib23","first-page":"1318","article-title":"Ethambutol dosage for the treatment of children: literature review and recommendations","volume":"10","author":"Donald","year":"2006","journal-title":"Int J Tuberc lung Dis"},{"issue":"2","key":"10.1016\/j.ijtb.2020.02.008_bib24","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0896-1549(03)00013-0","article-title":"Visual acuity and its measurement","volume":"16","author":"Kniestedt","year":"2003","journal-title":"Ophthalmol Clin North Am"},{"key":"10.1016\/j.ijtb.2020.02.008_bib25","series-title":"Color Vision Tests","year":"1981"},{"key":"10.1016\/j.ijtb.2020.02.008_bib26","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/0007-0971(86)90066-5","article-title":"Ocular toxicity following ethambutol in standard dosage","volume":"80","author":"Chaterjee","year":"1986","journal-title":"Br J Dis Chest"}],"container-title":["Indian Journal of Tuberculosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0019570720300378?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0019570720300378?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T03:58:39Z","timestamp":1758081519000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0019570720300378"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["S0019570720300378"],"URL":"https:\/\/doi.org\/10.1016\/j.ijtb.2020.02.008","relation":{},"ISSN":["0019-5707"],"issn-type":[{"value":"0019-5707","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ocular adverse events in drug sensitive TB patients on daily fixed dose combination anti-TB drugs: A record review study from Kerala, India","name":"articletitle","label":"Article Title"},{"value":"Indian Journal of Tuberculosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijtb.2020.02.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Tuberculosis Association of India. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}